Search Results

• • 1 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Serum sPD1 and sPDL1 as Biomarkers for Evaluating the Immune State of Lung Adenocarcinoma Patients.

  Authors:Yumin Wu, Hui Guo, Jiawei Yue, and Peng XuFrom:Journal of Immunology Research (Vol. 2022) Peer-Reviewed

  Nov. 25, 20225,753 words Article 1350LA large proportion of cancer patients benefit from immune checkpoint therapy, while few studies focused on the relationship between soluble PD1 (sPD1) and soluble PDL1 (sPDL1) in serum and immune status of patients. ILC2...